Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

ClinicalTrials.gov ID: NCT05593432

Public ClinicalTrials.gov record NCT05593432. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled Study of the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

Study identification

NCT ID
NCT05593432
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Incyte Corporation
Industry
Enrollment
64 participants

Conditions and interventions

Interventions

  • Ruxolitinib cream Drug
  • Vehicle cream Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 22, 2022
Primary completion
Oct 1, 2023
Completion
Feb 25, 2024
Last update posted
Oct 23, 2024

2022 – 2024

United States locations

U.S. sites
22
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
Cahaba Dermatology Birmingham Alabama 35244
Medical Dermatology Specialists Phoenix Phoenix Arizona 85006
Mayo Clinic Arizona Scottsdale Arizona 85259
Wallace of Beverly Hills Los Angeles California 90056
Northshore Medical Group Dermatology Skokie Skokie Illinois 60077
Dawes Fretzin Clinical Research Group Llc Indianapolis Indiana 46250
Delricht Clinical Research-Clinedge-Ppds Baton Rouge Baton Rouge Louisiana 70809
Delricht Research - Touro Medical Center New Orleans Louisiana 70115
Dermassociates Rockville Maryland 20850
Minnesota Clinical Study Center New Brighton Minnesota 55112
Jdr Dermatology Research Las Vegas Nevada 89148
OPTISKIN New York New York 10128
Bexley Dermatology Bexley Ohio 43209
Clinohio Research Services Columbus Ohio 43213
Apex Clinical Research Center Mayfield Heights Ohio 44124
Central Sooner Research Norman Oklahoma 73071
Oregon Medical Research Center Portland Oregon 97223
University of Pennsylvania-Perelman School of Medicine Philadelphia Pennsylvania 19104-5160
International Clinical Research Ic Research Murfreesboro Murfreesboro Tennessee 37130-2450
Arlington Center For Dermatology Arlington Texas 76011-3800
Austin Institute For Clinical Research Aicr Pflugerville Pflugerville Texas 78660
University of Utah Health Care Midvalley Health Center Dermatology Murray Utah 84107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05593432, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 23, 2024 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05593432 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →